Brief: Timber Pharmaceuticals Receives Notice Of Allowance From U.S. Patent And Trademark Office For BPX-01 And BPX-04
Sept 15 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FROM
U.S.
PATENT AND TRADEMARK OFFICE FOR BPX-01 AND BPX-04
* TIMBER PHARMACEUTICALS INC - USPTO FORMAL NOTICE CONFIRMS
INTENT
TO GRANT PATENT FOR PHARMACEUTICAL TETRACYCLINE COMPOSITIONS FOR
DERMATOLOGICAL USE
Source text for Eikon: ID:nGNE5lVCB1
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing